Brain Injury, 5 , 375-380
These therapies included nystatin suspension (4 mL of 100,000 units/mL, 3 times/day, topical) for 5 patients, nystatin suspension with clonazepam (0.5 mg/day, topical) for 1 patient, fluconazole suspension (2.5 mL of 10 mg/mL, 2 times/day, topical) for 1 patient, fluconazole suspension with clonazepam (0.5 mg/day, topical) for 1 patient, and both nystatin and itraconazole suspensions (5 mL of 10 mg/mL, 2 times/day, topical) for 1 patient
After first use, keep refrigerated and use within protocol timeframe FAQs: Glow Pen Peptide 1
Role of advanced glycation end products in cardiovascular disease
Studies have explored how this compound interacts with copper-dependent enzymes including lysyl oxidase, which plays a critical role in collagen and elastin crosslinking